PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026Analytical Chemistry2 citations

Ultrarapid Collection of High-Concentration Viral Samples from Small-Volume Exhaled Breath for Respiratory Virus Surveillance

View Full Paper
WLWeihao LiHGHan GaoMCMengqing Cheng

Key Points

  • This research aims to develop a rapid, noninvasive method for collecting high-concentration viral samples from exhaled breath for effective respiratory virus surveillance.
  • Developed a Phase-change Drywall Cyclone Sampler (PDC-sampler) for viral capture.
  • Optimized the design using computational fluid dynamics (CFD) for efficient phase-change condensation.
  • Implemented microfluidic chip for on-chip RNA lysis from collected samples.
  • Achieved detection limits of 5-9 copies of viral RNA per exhalation for SARS-CoV-2 and H1N1 influenza.
  • Produced ∼20 μL of high-concentration RNA lysate from a single exhalation in 10 seconds.
  • Demonstrated rapid and sensitive viral detection in a small-volume, easily deployable format.

Abstract

Rapid and sensitive detection of airborne respiratory viruses from exhaled breath is essential for early diagnosis and outbreak control, yet current strategies suffer from low capture efficiency and sample dilution. Here, we present a fully automated, noninvasive Phase-change Drywall Cyclone Sampler (PDC-sampler), which integrates phase-change condensation with a CFD-optimized cyclone gas-liquid separator. This design rapidly condenses viral aerosols─particularly those <5 μm─into microdroplets and directs them into a stable spiral liquid stream, thereby enhancing capture efficiency and producing a small-volume, high-concentration liquid sample. The collected condensate is directly coupled to a microfluidic RNA-release chip, enabling on-chip viral RNA lysis. From a single tidal exhalation (∼0.5 L), the system generates ∼20 μL of high-concentration RNA lysate in 10 s of on-device processing (sample-to-lysate), directly compatible with nucleic acid detection. Combined with ddPCR, it achieves detection limits as low as 5-9 copies per exhalation for pathogens including SARS-CoV-2 and H1N1 influenza. This ultrarapid, small-volume, sample-to-result workflow provides a scalable, field-deployable solution for point-of-care diagnosis and real-time respiratory virus surveillance.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/69aa6f3c531e4c4a9ff59456https://doi.org/10.1021/acs.analchem.5c06572
Ask AI
Helpful
Bookmark
Share
View Full Paper